Total Funding
53
40
Total FundingSeries B raised
Growth Score
-4 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
33816
Purespring Therapeutics is a gene therapy company that provides treatments for different kidney diseases.
- Haseeb Ahmad: Chief Executive OfficerPast Role: Novartis, President
Pille Harrison: VP Clinical DevelopmentPast Role: Alpine Immune Sciences, VP Clinical Development
About the Company
Purespring Therapeutics is a pioneering company focused on developing gene therapies for various kidney diseases, particularly targeting podocytes, which are specialized kidney cells. The company is among the first globally to employ AAV gene therapy specifically for kidney conditions, aiming to tackle one of the most challenging areas in medicine.
